Essential guidelines recommending particle-retentive filters

Dr Volker Luibl

Dr Volker Luibl

Sr. Marketing Manager Medical Content | Pall Medical, part of Cytiva

IV Filtration

SUMMARY:

In recent years, several professional societies - have published recommendations on the use of in‑line IV filters.

Particulates  were the main concerns and drivers for the recommendations across the societies. With the majority recommending 0.2 µm and/or 1.2 µm in-line IV filters. This is a summary of the guidelines for particle retentive filters.

 

Society 

Country 

Year 

Statement

INS

USA

2022

Reduce particulate matter in critically ill patients that can cause thrombogenesis, impaired microcirculation, and alter immune response. Use a 1.2-micron filter for all PN solutions including PN solutions with lipids [“total nutrient admixtures” (TNA)], dextrose-amino acid admixtures, and lipid injectable emulsions.

ASPEN

USA

2020

In-line intravenous filters serve a critical purpose in reducing exposure to particulate matter during PN therapy. Based on best available evidence and guidance from scientific and regulatory agencies, ASPEN recommends using a 1.2 micron in-line filter for administration of TNAs, dextrose-amino acid admixtures and ILE.

IRSPEN

Ireland

2020

The IRSPEN states that PN solutions may  contain particulate matter and biochemical interactions can result in chemical precipitations in addition to the risk of bacterial contamination. It is recommended that all PN solutions are administered via an infusion set containing a terminal filter. A 1.2-to-1.5-micron filter is recommended for 3-in-1 admixtures.

HAS

France

2018

The HAS recommends using antibacterial (0.22 µm) and particulate (1.2 µm) in-line filters.

ESPGHAN, ESPEN, ESPR, CSPEN

China & Europe

2018

PN solutions contain particulate matter, and biochemical interactions can lead to chemical precipitates and emulsion instability. PN solutions may be administered through a terminal filterlipid emulsions (or all-in-one mixes) can be passed through a membrane pore size of 1.2 - 1.5 µm.

Aqueous solutions can be passed through a 0.22 µm filter.

KRINKO

Germany

2017

Particle filters should be used for intensive care patients in the infusion system (air separation, less systemic inflammatory response reaction).

JSPEN

Japan

2013

IV in-line filters not only trap microorganisms but also capture foreign substances such as glass pieces and sediments caused by changes in formulation and have the effect of preventing air embolism.

BPNG

UK

2001

Appropriate filters shouldbe used during the administration of PN to patients who require intensive or prolonged parenteral therapy, the immunocompromised, neonates and children, and patients receiving home PN because of the large volume of potentially particulate-contaminated fluid administered and their increased susceptibility to the detrimental effects of particulate contamination.

 

References

1.2021 Infusion Therapy Standards of Practice Updates. J Infus Nurs. 2021 Jul-Aug 01;44(4):189-190.

2.Worthington P, Gura KM, Kraft MD, Nishikawa R, Guenter P, Sacks GS. et al. Update on the Use of Filters for Parenteral Nutrition: An ASPEN Position Paper. Nutr Clin Pract. 2021; 36(1):29-39. doi.10.1002/ncp.10587.

3.Irish Society for Clinical Nutrition & Metabolism. 2020. Guideline on the Use of Parenteral Nutrition in Neonatal and Paediatric Units. Revision date: 2023 Jul. Version 2.0. Guideline no. CSPD001/2017. https://www.hse.ie/eng/about/who/cspd/ncps/paediatrics-neonatology/resources/guideline-on-the-use-of-parenteral-nutrition-in-neonatal-and-paediatric-units.pdf

4.Haute Autorité de Santé. Recommandation de bonne pratique. Nutrition parentérale en néonatologie. French. 2018 Apr 4. https://www.has-sante.fr/jcms/c_2859140/en/nutrition-parenterale-en-neonatologie-recommandation-de-bonne-pratique

5.Puntis JWL, Hojsak I, Kziazyk J, ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Organisational aspects. Clin Nutr. 2018;37(6 Pt B):2392-2400. doi:10.1016/j.clnu.2018.06.953.

6.Prävention von Infektionen, die von Gefäßkathetern ausgehen: Teil 1 – Nichtgetunnelte zentralvenöse Katheter Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Feb;60(2):171-206. German.

7.Japanese Society for Clinical Nutrition and Metabolism. 2013. Japanese.

8.Inoue Y. The Japanese Journal of Surgical Metabolism and Nutrition. 2008;42:11-18.

9.Inoue Y. et al. The Japanese Journal of Surgical Metabolism and Nutrition. 2006;40:229-237.

10.Bethune K, Allwood M, Grainger C, Wormleighton C, British Pharmaceutical Nutrition Group Working Party. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition. 2001;17(5):403-408. doi:10.1016/s0899-9007(01)00536-6.

Need expert help with medical filtration? We can assist you!

Share your needs and our specialists will deliver tailored solutions.

* Products displayed on this website may not hold regulatory approval, authorisation, or clearance in all countries, and their availability is subject to regional regulatory requirements. For local office contact information, visit our contact page